NEW YORK (GenomeWeb) – RainDance Technologies today pulled its planned initial public offering citing market conditions. 

In a document filed with the US Securities and Exchange Commission, the Billerica, Massachusetts-based digital PCR and targeted sequence enrichment firm said that it "has determined at this time not to proceed with the offering due to market conditions." It did not provide further details, but RainDance's decision follows a sharp sell-off in the public markets amid concerns about macroeconomic conditions. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.